We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDPH
RNS Number : 0335Z
Dechra Pharmaceuticals PLC
15 September 2020
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to a ris.
Date: 15 September 2020
Hot Features
Premium
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Approved Share Option Scheme
----------------------------------------
Period of return: From: 15 March 2020 To: 14 September 2020
------------------------ -------------- ---- ------------------
Balance of unallotted securities under scheme(s) from previous return: 3,844
----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 0
----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 0
----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 3,844
----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to a ris.
Date: 15 September 2020
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Unapproved Share Option Scheme
----------------------------------------
Period of return: From: 15 March 2020 To: 14 September 2020
------------------------ -------------- ---- ------------------
Balance of unallotted securities under scheme(s) from previous return: 76,320
----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 0
----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 10,000
----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 66,320
----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to a ris.
Date: 15 September 2020
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: SAYE Scheme
----------------------------------------
Period of return: From: 15 March 2020 To: 14 September 2020
------------------------ -------------- ---- ------------------
Balance of unallotted securities under scheme(s) from previous return: 46,493
----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 0
----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 876
----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 45,617
----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to a ris.
Date: 15 September 2020
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: Global Save As You Earn Plan 2018
----------------------------------------
Period of return: From: 15 March 2020 To: 14 September 2020
------------------------ -------------- ---- ------------------
Balance of unallotted securities under scheme(s) from previous return: 70,000
----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 0
----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 0
----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 70,000
----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to a ris.
Date: 15 September 2020
Name of applicant: Dechra Pharmaceuticals PLC
Name of scheme: 2017 Long Term Incentive Plan
----------------------------------------
Period of return: From: 15 March 2020 To: 14 September 2020
------------------------ -------------- ---- ------------------
Balance of unallotted securities under scheme(s) from previous return: 175,000
----------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 0
----------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 0
----------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 175,000
----------------------------------------
Name of contact: Melanie Hall
Telephone number of contact: 01606 814 730
--------------
, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRFIFETADIELII
(END) Dow Jones Newswires
September 15, 2020 04:59 ET (08:59 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
